Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,64 EUR | +0,34% | -0,34% | +6,20% |
22/04 | Degroof Petercam verhoogt koersdoel Fagron licht | AM |
12/04 | Berenberg verlaagt koersdoel Fagron licht | AM |
Vakgebied
Aantal werknemers: 3 282
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Fagron North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99% |
Fagron EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08% |
Fagron Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99% |
EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08% |
Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 46 | 27-11-17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01-05-08 |
Vera Bakker
COO | Chief Operating Officer | 52 | 09-05-22 |
Karen Berg
IRC | Investor Relations Contact | - | 01-09-21 |
Marc van der Aa
PRN | Corporate Officer/Principal | - | - |
Johan Verlinden
LAW | General Counsel | - | 01-04-13 |
Corporate Officer/Principal | 54 | 01-01-08 | |
Celine Caveye
HRO | Human Resources Officer | - | 01-01-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Koen Hoffman
CHM | Chairman | 56 | 01-08-16 |
Director/Board Member | 64 | 01-01-19 | |
Chief Executive Officer | 46 | 27-11-17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01-05-08 |
Director/Board Member | 53 | 09-05-22 | |
Vera Bakker
COO | Chief Operating Officer | 52 | 09-05-22 |
Neeraj Sharma
BRD | Director/Board Member | 52 | 09-05-22 |
Director/Board Member | 53 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 73 228 904 | 69 227 472 ( 94,54 %) | 241 999 ( 0,3305 %) | 94,54 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
FAGRON as
FAGRON as Pharmaceuticals: MajorHealth Technology FAGRON as operates as wholesaler of pharmaceutical raw materials, creams and packaging to pharmacists. The company was founded on May 11, 1992 and is headquartered in Olomouc, Czech Republic. |
Pharmaceuticals: Major
|
Arseus Capital NV
Arseus Capital NV Financial ConglomeratesFinance Part of Fagron NV, Arseus Capital NV provides financial services. The private company is based in Nazareth, Belgium. The CEO of the Belgian company is Cornelia de Jong. |
Financial Conglomerates
|
Dr. Kulich Pharma sro
Dr. Kulich Pharma sro Pharmaceuticals: MajorHealth Technology Dr. Kulich Pharma sro engages in the pharmaceuticals industry. It offers drugs, pharmaceutical materials, chemicals, as well as laboratory services. The company was founded by Jan Kulich in 1992 and is headquartered in Hradec Kralove, Czech Republic. |
Pharmaceuticals: Major
|
Fagron BV
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,20% | 1,37 mld. | |
+24,17% | 562 mld. | |
-6,33% | 358 mld. | |
+19,90% | 322 mld. | |
+7,95% | 297 mld. | |
+13,45% | 219 mld. | |
+6,04% | 199 mld. | |
-10,51% | 196 mld. | |
-12,26% | 149 mld. | |
-6,47% | 146 mld. |
- Beurs
- Aandelen
- Koers FAGR
- Onderneming Fagron N.V.